Intermittent preventive treatment for the prevention of malaria during pregnancy in high transmission areas

Malaria Journal

Volumn 6, Issue , 2007, Pages

  Briand, Valérie ^a   Cottrell, Gilles ^a   Massougbodji, Achille ^b   Cot, Michel ^a  

^a INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^b Parasitology and Mycology Education and Research Unit (UER)   (Benin)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ARTEMISININ; AZITHROMYCIN; CHLORPROGUANIL PLUS DAPSONE; FANSIDAR; MEFLOQUINE; PIPERAQUINE; ANTIMALARIAL AGENT; PYRIMETHAMINE; SULFADOXINE; SULFADOXINE-PYRIMETHAMINE; UNCLASSIFIED DRUG;

CLINICAL PRACTICE; CLINICAL TRIAL; DIZZINESS; DRUG EFFICACY; DRUG HALF LIFE; DRUG INTERMITTENT THERAPY; DRUG MONITORING; DRUG SAFETY; FETUS GROWTH; HEALTH CARE PERSONNEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INTERMITTENT PREVENTIVE TREATMENT; MALARIA; MATERNAL MORBIDITY; MORTALITY; NAUSEA; NOTE; PREGNANCY OUTCOME; PREGNANT WOMAN; PRENATAL CARE; PROPHYLAXIS; RECOMMENDED DRUG DOSE; SINGLE DRUG DOSE; VOMITING; WORLD HEALTH ORGANIZATION; DRUG COMBINATION; DRUG RESISTANCE; FEMALE; PREGNANCY; PREGNANCY COMPLICATION; REVIEW;

ANTIMALARIALS; DRUG COMBINATIONS; DRUG RESISTANCE; FEMALE; HUMANS; MALARIA; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; PYRIMETHAMINE; SULFADOXINE;

EID: 37749002548     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-6-160     Document Type: Note

References (49)

1. A strategic framework for malaria prevention and control during pregnancy in the Africa Region. WHO, World HealthOrganization, Geneva 2004 AFR/MAL/04/01
2. The burden of malaria in pregnancy in malaria-endemic areas. R Steketee B Nahlen M Parise C Menendez, Am J Trop Med Hyg 2001 64 28 35 11425175
3. The effect of malaria and malaria prevention in pregnancy on offspring birthweight, prematurity, and intrauterine growth retardation in rural Malawi. R Steketee J Wirima A Hightower L Slutsker D Heymann J Breman, Am J Trop Med Hyg 1996 55 33 41 8702035
4. The contribution of low birth weight to infant mortality and childhood morbidity. M McCormick, N Engl J Med 1985 312 82 90 3880598
5. Rates and risk factors for mortality during the first two years of life in rural Malawi. P Bloland L Slutsker R Steketee J Wirima D Heymann J Breman, Am J Trop Med Hyg 1996 55 82 86 8702044
6. The burden of co-infection with human immunodeficiency virus type 1 and malaria in pregnant women in sub-saharan Africa. F Ter Kuile M Parise F Verhoeff V Hudhayakumar R Newman A van Eijk S Rogerson R Steketee, Am J Trop Med Hyg 2004 71 41 54 15331818
7. Maternal placental infection with Plasmodium falciparum and malaria morbidity during the first 2 years of life. JY Le Hesran M Cot P Personne N Fievet B Dubois M Beyeme C Boudin P Deloron, Am J Epidemiol 1997 146 826 831 9384203
8. Maternal malaria and gravidity interact to modify infant susceptibility to malaria. T Mutabingwa M Bolla J Li G Domingo X Li M Fried P Duffy, PLoS Med 2005 2 e407 16259531 10.1371/journal.pmed.0020407
9. Drugs for preventing malaria-related illness in pregnant women and death in the newborn. P Garner A Gulmezoglu, Cochrane Database Syst Rev 2003 1 CD000169 12535391
10. Malaria prevention strategies. M Cot P Deloron, Br Med Bull 2003 67 137 148 10.1093/bmb/ldg003 14711760
11. The efficacy of antimalarial regimens containingsulfadoxine-pyrimethamine and/or chloroquine in preventing peripheral and placental Plasmodium falciparum infection among pregnant women in Malawi. L Shultz R Steketee A Macheso P Kazembe L Chitsulo J Wirima, Am J Trop Med Hyg 1994 51 515 522 7985742
12. Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial. C Shulman E Dorman F Cutts K Kawuondo J Bulmer N Peshu K Marsh, Lancet 1999 353 632 636 10.1016/S0140-6736(98)07318-8 10030329
13. Prevention of anaemia in pregnancy using insecticide-treated bednets and sulfadoxine-pyrimethamine in a highly malarious area of Kenya: a randomizedcontrolled trial. J Njagi P Magnussen B Estambale J Ouma B Mugo, Trans R Soc Trop Med Hyg 2003 97 277 282 10.1016/S0035-9203(03)90141-6 15228241
14. Impact of a double dose of sulphadoxine-pyrimethamine to reduce prevalence of pregnancy malaria in southern Mozambique. K Challis N Osman M Cotiro G Nordahl M Dgedge S Bergstrom, Trop Med Int Health 2004 9 1066 1073 10.1111/j.1365-3156.2004.01307.x 15482398
15. Comparison of intermittent preventive treatment with chemoprophylaxis for the prevention of malaria during pregnancy in Mali. K Kayentao M Kodio R Newman H Maiga D Doumtabe A Ongoiba D Coulibaly A Keita B Maiga M Mungai M Parise O Doumbo, J Infect Dis 2005 191 109 116 10.1086/426400 15593011
16. Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection. M Parise J Ayisi B Nahlen L Schultz J Roberts A Misore R Muga A Oloo R Steketee, Am J Trop Med Hyg 1998 59 813 822 9840604
17. Intermittent sulfadoxine-pyrimethamine in pregnancy: effectiveness against malaria morbidity in Blantyre, Malawi, in 1997-99. S Rogerson E Chaluluka M Kanjala P Mkundika C Mhango M Molyneux, Trans R Soc Trop Med Hyg 2000 94 549 553 10.1016/S0035-9203(00)90083-X 11132387
18. An evaluation of the effects of intermittent sulfadoxine-pyrimethamine treatment in pregnancy on parasite clearance and risk of low birthweight in rural Malawi. F Verhoeff B Brabin L Chimsuku P Kazembe W Russell R Broadhead, Ann Trop Med Parasitol 1998 92 141 150 10.1080/00034989859979 9625909
19. Effectiveness of intermittent preventive treatment with sulphadoxine-pyrimethamine for control of malaria in pregnancy in western Kenya: a hospital-based study. A Van Eijk J Ayisi F ter Kuile J Otieno A Misore J Odondi D Rosen P Kager R Steketee B Nahlen, Trop Med Int Health 2004 9 351 360 10.1111/j.1365-3156.2004.01196.x 14996364
20. Malaria in pregnancy and its consequences for the infant in rural Malawi. F H Verhoeff B J Brabin L Chimsuku P Kazembe R L Broadhead, Ann Trop Med Parasitol 1999 93 Suppl 1 25 33 10.1080/00034989957718
21. Randomized Trial of 2-Dose versus Monthly Sulfadoxine-Pyrimethamine Intermittent Preventive Treatment for Malaria in HIV-Positive and HIV-Negative Pregnant Women in Malawi. S Filler P Kazembe M Thigpen A Macheso M Parise R Newman R Steketee M Hamel, J Infect Dis 2006 194 286 293 10.1086/505080 16826475
22. Is malarial placental infection related to peripheral infection at any time of pregnancy? G Cottrell JY Mary D Barro M Cot, Am J Trop Med Hyg 2005 73 1112 1118 16354822
23. Insecticide-treated nets for preventing malaria in pregnancy. C Gamble J Ekwaru F ter Kuile, Cochrane Database Syst Rev 2006 CD003755 16625591
24. The fetal period. Keith L Moor, The developing human: Clinically oriented embryology Saunders WB. London Fourth 1988
25. The effects of Plasmodium falciparum and P. vivax infections on placental histopathology in an area of low malaria transmission. R McGready B Davison K Stepniewska T Cho H Shee A Brockman R Udomsangpetch S Looareesuwan N White S Meshnick F Nosten, Am J Trop Med Hyg 2004 70 398 407 15100454
26. A difference in mortality rate and incidence of kernicterus among premature infants allotted to two prophylactic antibacterial regimens. D Andersen W Blanc D Crozier W Silverman, Pediatrics 1956 18 614 625 13370229
27. Antimalarial drug toxicity: a review. W Taylor N White, Drug Saf 2004 27 25 61 10.2165/00002018-200427010-00003 14720085
28. Intermittent presumptive treatment for malaria. N White, PLoS Med 2005 2 e3 15696210 10.1371/journal.pmed.0020003
29. Malaria during pregnancy: a priority area of malaria research and control. C Menendez, Parasitol Today 1995 11 178 183 10.1016/0169-4758(95)80151- 0 15275350
30. A randomized, placebo-controlled trial of intermittent preventive treatment with sulphadoxine-pyrimethamine in Gambian multigravidae. A Mbaye K Richardson B Balajo S Dunyo C Shulman P Milligan B Greenwood G Walraven, Trop Med Int Health 2006 11 992 1002 10.1111/j.1365-3156.2006.01649.x 16827700
31. Can malaria chemoprophylaxis be restricted to first pregnancies? A Greenwood C Menendez P Alonso S Jaffar P Langerock S Lulat J Todd B M'Boge N Francis B Greenwood, Trans R Soc Trop Med Hyg 1994 88 681 682 10.1016/0035-9203(94)90228-3 7886770
32. Global strategy plan 2005-2015. WHO, World Health Organization, Geneva 2005 http://www.rollbackmalaria.org/forumV/docs/gsp_en.pdf
33. Reaching the Abuja target for intermittent preventive treatment of malaria in pregnancy in African women: a review of progress and operational challenges. J Hill P Kazembe, Trop Med Int Health 2006 11 409 418 10.1111/j.1365-3156.2006.01585.x 16553924
34. Prevention of malaria during pregnancy in West Africa: policy change and the power of subregional action. R Newman A Moran K Kayentao E Benga-De M Yameogo O Gaye O Faye Y Lo P Moreira O Doumbo M Parise R Steketee, Trop Med Int Health 2006 11 462 469 10.1111/j.1365-3156.2006.01593.x 16553929
35. Intermittent preventive treatment during pregnancy in Benin: a randomized, open, and equivalent trial comparing sulfadoxine-pyrimethamine with mefloquine. National Institutes of Health USA, National Institutes of Health USA 2006 http://www.clinicaltrials.gov/ct/show/NCT00274235
36. World Malaria Report 2005. WHO, World Health Organization, Geneva 2005 http://rbm.who.int/wmr2005/
37. Dramatic decreased therapeutic efficacy of chloroquine and sulfadoxine-pyrimethamine, but not mefloquine, in southern Benin. A Aubouy N Fievet G Bertin JC Sagbo H Kossou D Kinde-Gazard R Kiniffo A Massougbodji P Deloron, Trop Med Int Health 2006 12 886 894
38. Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy. F ter Kuile A van Eijk S Filler, JAMA 2007 297 2603 2616 10.1001/jama.297.23.2603 17579229
39. Malaria in pregnancy: its relevance to safe-motherhood programmes. C E Shulman, Ann Trop Med Parasitol 1999 93 Suppl 1 59 66 10.1080/00034989957745
40. Nutrition and maternal mortality in the developing world. D Rush, Am J Clin Nutr 2000 72 Suppl 1 212S 240S
41. Malaria in pregnancy and the endemicity spectrum: what can we learn? F Nosten S Rogerson J Beeson R McGready T Mutabingwa B Brabin, Trends Parasitol 2004 20 425 432 10.1016/j.pt.2004.06.007 15324733
42. Malaria prevention during pregnancy in unstable transmission areas: the highlands of Madagascar. M Cot L Brutus V Pinell H Ramaroson A Raveloson D Rabeson A Rakotonjanabelo, Trop Med Int Health 2002 7 565 572 10.1046/j.1365-3156.2002.00897.x 12100438
43. Is chloroquine chemoprophylaxis still effective to prevent low birth weight? Results of a study in Benin. L Denoeud N Fievet A Aubouy P Ayemonna R Kiniffo A Massougbodji M Cot, Malar J 2006 6 27 10.1186/1475-2875-6-27
44. Comparative efficacy of chloroquine and sulphadoxine-pyrimethamine in pregnant women and children: a meta-analysis. G Kalanda J Hill F Verhoeff B Brabin, Trop Med Int Health 2006 11 569 577 10.1111/j.1365-3156.2006.01608.x 16640608
45. Post-marketing surveillance of prophylactic mefloquine (Lariam) use in pregnancy. B Vanhauwere H Maradit L Kerr, Am J Trop Med Hyg 1998 58 17 21 9452285
46. Safety of mefloquine and other antimalarial agents in the first trimester of pregnancy. P Phillips-Howard R Steffen L Kerr B Vanhauwere J Schildknecht E Fuchs R Edwards, J Travel Med 1998 5 121 126 10.1111/j.1708-8305.1998.tb00484.x 9772329
47. Mefloquine prophylaxis prevents malaria during pregnancy: a double-blind, placebo-controlled study. F Nosten F ter Kuile L Maelankiri T Chongsuphajaisiddhi L Nopdonrattakoon S Tangkitchot E Boudreau D Bunnag N White, J Infect Dis 1994 169 595 603 8158032
48. Prevention and management of severe anaemia inpregnancy. WHO, World Health Organization, Geneva 1993 WHO/FHE/MSM/93.5
49. Safety, efficacy and determinants of effectiveness of antimalarial drugs during pregnancy: implications for prevention in Plasmodium falciparum-endemic sub-Saharan Africa. R Newman M Parise L Slutsker B Nahlen R Steketee, Trop Med Int Health 2003 8 488 506 10.1046/j.1365-3156.2003.01066.x 12791054